Close

Ratings by Baird (Jack Allen)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/3/2022 Fate Therapeutics FATE New Coverage Outperform
(N/A)
22.63
(33.82)
49.45% Details
6/3/2022 Allogene ALLO New Coverage Neutral
(N/A)
7.70
(17.25)
124.03% Details
6/3/2022 Voyager Therapeutics VYGR New Coverage Outperform
(N/A)
6.13
(6.07)
-0.98% Details
6/3/2022 Homology Medicines FIXX New Coverage Outperform
(N/A)
1.45
(2.76)
90.34% Details
6/3/2022 Intellia Therapeutics NTLA New Coverage Neutral
(N/A)
42.86
(67.74)
58.05% Details
3/9/2022 Taysha Gene Therapies TSHA New Coverage Outperform
(N/A)
5.74
(4.10)
-28.57% Details
12/3/2021 Vor Biopharma, Inc. VOR New Coverage Outperform
(N/A)
11.32
(5.40)
-52.3% Details
11/9/2021 MiNK Therapeutics INKT New Coverage Outperform
(N/A)
17.38
(1.71)
-90.16% Details
10/22/2021 Decibel Therapeutics Inc DBTX New Coverage Outperform
(N/A)
7.47
(4.33)
-42.03% Details
8/13/2021 Instil Bio Inc TIL New Coverage Outperform
(N/A)
16.27
(6.95)
-57.28% Details